ResMed Inc.
RMD
$251.69
$3.111.25%
NYSE
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 0.75% | 4.70% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.75% | 4.70% | |||
| Cost of Revenue | -1.01% | 4.72% | |||
| Gross Profit | 1.97% | 4.69% | |||
| SG&A Expenses | 1.53% | 1.10% | |||
| Depreciation & Amortization | -1.83% | -2.06% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.07% | 3.30% | |||
| Operating Income | 2.16% | 7.73% | |||
| Income Before Tax | -0.15% | 9.08% | |||
| Income Tax Expenses | -28.56% | 2.16% | |||
| Earnings from Continuing Operations | 5.93% | 10.68% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 5.93% | 10.68% | |||
| EBIT | 2.16% | 7.73% | |||
| EBITDA | 1.40% | 7.45% | |||
| EPS Basic | 5.99% | 10.72% | |||
| Normalized Basic EPS | 0.92% | 9.30% | |||
| EPS Diluted | 5.98% | 10.90% | |||
| Normalized Diluted EPS | 1.03% | 9.35% | |||
| Average Basic Shares Outstanding | -0.06% | -0.03% | |||
| Average Diluted Shares Outstanding | -0.18% | -0.08% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | -0.06% | -0.10% | |||